Protection from doxorubicin-induced cardiomyopathy using the modified anthracycline N-benzyladriamycin-14-valerate (AD 198). [electronic resource]
Producer: 20101021Description: 223-30 p. digitalISSN:- 1521-0103
- AMP-Activated Protein Kinase Kinases
- Animals
- Antibiotics, Antineoplastic -- antagonists & inhibitors
- Blotting, Western
- Calcium -- pharmacology
- Cardiomyopathies -- chemically induced
- Cardiotonic Agents -- pharmacology
- Doxorubicin -- analogs & derivatives
- Electrophoresis, Polyacrylamide Gel
- Indicators and Reagents
- Male
- Mass Spectrometry
- Myocytes, Cardiac -- drug effects
- Nitric Oxide Synthase Type II -- biosynthesis
- Phosphorylation
- Poly Adenosine Diphosphate Ribose -- pharmacology
- Protein Kinase C-epsilon -- antagonists & inhibitors
- Protein Kinases -- metabolism
- Rats
- Rats, Wistar
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.